Back
Adaptive Biotechnologies Stock Price Chart
Sponsored
ADPT
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
38
ADPT
Adaptive Biotechnologies
Last Price:
4.67
Seasonality Move:
-1.77%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.63 | Sell |
20-day SMA: | 5.23 | Sell |
50-day SMA: | 4.95 | Sell |
200-day SMA: | 3.98 | Buy |
8-day EMA: | 5.38 | Sell |
20-day EMA: | 5.31 | Sell |
50-day EMA: | 5.01 | Sell |
200-day EMA: | 4.56 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 41.81 | Sell |
Chaikin Money Flow: | -1263705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.6 - 5.68) | Sell |
Bollinger Bands (100): | (4.03 - 5.19) | Buy |
Adaptive Biotechnologies Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 4.68 while ADPT 8-day simple moving average is 5.63, which is a Sell signal.
- The stock price of ADPT is 4.68 while Adaptive Biotechnologies 20-day SMA is 5.23, which makes it a Sell.
- Adaptive Biotechnologies 50-day simple moving average is 4.95 while ADPT share price is 4.68, making it a Sell technically.
- ADPT stock price is 4.68 and Adaptive Biotechnologies 200-day simple moving average is 3.98, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Sell
38
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a Sell
The current Adaptive Biotechnologies [ADPT] share price is $4.68. The Score for ADPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
690.67M
Price in USD:
4.68
Share Volume:
1.39M
Adaptive Biotechnologies 52-Week Range
52-Week High:
6.70
52-Week Low:
2.28
Sell
38
Adaptive Biotechnologies (ADPT)
is a Sell
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?
The Adaptive Biotechnologies stock price is 4.68 USD today. -
Will ADPT stock go up or go down?
Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptive Biotechnologies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is overvalued.
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 4.68 while ADPT 8-day exponential moving average is 5.38, which is a Sell signal.
- The stock price of ADPT is 4.68 while Adaptive Biotechnologies 20-day EMA is 5.31, which makes it a Sell.
- Adaptive Biotechnologies 50-day exponential moving average is 5.01 while ADPT share price is 4.68, making it a Sell technically.
- ADPT stock price is 4.68 and Adaptive Biotechnologies 200-day simple moving average is 4.56, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.26 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
- ADPT Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Adaptive Biotechnologies is a Buy
- Adaptive Biotechnologies Relative Strength Index (RSI) is 41.81, which suggest Adaptive Biotechnologies is oversold
- The Bollinger Bands (25) for Adaptive Biotechnologies is (4.6 - 5.68), which suggest Adaptive Biotechnologies is a Buy
- The Bollinger Bands (100) for Adaptive Biotechnologies is (4.03 - 5.19), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.